U.S. markets closed

Fresenius SE & Co. KGaA (FRE.DE)

XETRA - XETRA Precio retrasado. Divisa en EUR.
Añadir a la lista de seguimiento
25.70+0.33 (+1.30%)
Al cierre: 05:39PM CET

Fresenius SE & Co. KGaA

Else-Kroener-Strasse 1
Bad Homburg vor der Höhe 61352
Germany
49 6172 608 2487
https://www.fresenius.com

Sector(es)Healthcare
IndustriaMedical Care Facilities
Empleados a tiempo completo319,691

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Mr. Michael SenCEO, Pres & Chairman of Management Board - Fresenius Management SE2.23MN/D1968
Dr. Francesco De MeoMember of Management Board - Fresenius Management SE2.35MN/D1963
Dr. Ernst WastlerMember of Management Board - Fresenius Management SE1.8MN/D1958
Dr. Sebastian BiedenkopfChief Legal Officer, HR, Labor Relations Director, Risk Mgmt & Member of Mgmt. Board1.51MN/D1964
Ms. Sara HennickenChief Financial OfficerN/DN/D1980
Dr. Carla KriwetMembers of Management Board - Fresenius Management SEN/DN/D1971
Mr. Markus GeorgiSr. VP of Investor RelationsN/DN/DN/D
Matthias LinkSr. VP Corp. CommunicationsN/DN/DN/D
Los importes son a partir de 31 de diciembre de 2021 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en EUR.

Descripción

Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune and oncology diseases; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operates 90 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 49 hospitals, 88 outpatient clinics, and approximately 300 risk prevention centers in Spain. This segment also provides services in the field of fertility treatments through 33 clinics and additional 39 sites across 10 countries on 3 continents. The Fresenius Vamed segment manages projects and offers services for hospitals and other health care facilities. This segment provides project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

Gestión corporativa

La calificación ISS Governance QuickScore de Fresenius SE & Co. KGaA a partir del 1 de noviembre de 2022 es 1. Las puntuaciones principales son Auditoría: 1; Junta: 3; Derechos del accionista: 1; Compensación: 1.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.